Information

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm

Key Opinions in Medicine

  • Register
  • Login
Skip to content
  • Home
  • Issues
    • Allergy & Immunology
    • Cardiology
    • Conference
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology
    • General Medicine
    • Haematology
    • Hepatology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Nursing
    • Obstetrics & Gynaecology
    • Oncology
    • Paediatrics
    • Psychiatry
    • Rheumatology
    • Surgery Insights
    • Urology
  • About
  • Contact
  • Register
  • Login

Practical Use of EVRYSDI®▼ (Risdiplam) in Individuals with Spinal Muscular AtrophyBack

March 6, 2024

Practical Use of EVRYSDI®▼ (Risdiplam) in Individuals with Spinal Muscular Atrophy

Search News

News Archives

    Popular Issues

    Konkurrenz für den Therapiestandard

    MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence-based use

    Register

    Register

    Sign up for free access to Wiley’s Key Opinions in Medicine to keep up to date with latest trends and key developments within your specialty area.

    Share

    Copyright © 2000-2025 by John Wiley & Sons, Inc., or related companies. All rights reserved.
    Review our privacy policy. Cookie Preferences.
    Web design and marketing agency Leamington Spa